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The phosphoinositides (PIs) function as efﬁcient and ﬁnely
tuned switches that control the assembly–disassembly cycles
of complex molecular machineries with key roles in mem-
brane trafﬁcking. This important role of the PIs is mainly
due to their versatile nature, which is in turn determined by
their fast metabolic interconversions. PIs can be tightly
regulated both spatially and temporally through the many
PI kinases (PIKs) and phosphatases that are distributed
throughout the different intracellular compartments. In
spite of the enormous progress made in the past 20 years
towards the deﬁnition of the molecular details of PI–protein
interactions and of the regulatory mechanisms of the indivi-
dual PIKs and phosphatases, important issues concerning
the general principles of the organisation of the PI system
and the coordination of the different PI-metabolising en-
zymes remain to be addressed. The answers should come
from applying a systems biology approach to the study of the
PI system, through the integration of analyses of the protein
interaction data of the PI enzymes and the PI targets with
those of the ‘phenomes’ of the genetic diseases that involve
these PI-metabolising enzymes.
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Introduction
The phosphoinositides (PIs) derive from reversible phosphor-
ylation in three of the ﬁve hydroxyl groups of the inositol
headgroup of the ‘parent’ PI, phosphatidylinositol (PtdIns).
This process operates through the large repertoire of PI
kinases (PIKs) and PI phosphatases that are present in
practically all cell compartments (Figures 1 and 2). The
combined activities of the various isoforms of these PIKs
and PI phosphatases provide a dynamic equilibrium between
the seven distinct, but interconvertible, PI species (Figure 1).
It is now clear that all of these different PIs are ‘active’ in their
own right, rather than many just serving as intermediates in
the synthesis of the higher phosphorylated species.
Although they are quantitatively minor components of cell
membranes, the PIs regulate many fundamental processes in
the cell, including membrane trafﬁcking, cell growth, cytos-
keleton remodelling and nuclear events. These regulatory
actions are mainly due to their ability to control the sub-
cellular localisation and activation of various effector pro-
teins that possess PI-binding domains, such as the PH, FYVE,
PX, ENTH, PH-GRAM, FERM and GLUE domains (Lemmon,
2008).
Here, we will focus on the role of the PIs in membrane
trafﬁcking, where they can function as ‘local’ organisers of
membrane domains and controllers of membrane sorting and
deformation machineries, and as integrators of membrane
trafﬁcking within other cell function modules, such as the
cytoskeleton, signalling, lipid metabolism and energy control.
Although we refer to excellent recent reviews for an update
on the enormous progress made towards the deﬁnition of the
roles, regulation and mechanisms of action of the PIs (Di
Paolo and De Camilli, 2006; Engelman et al, 2006; Gamper
and Shapiro, 2007; Krauss and Haucke, 2007; Strahl and
Thorner, 2007; Yeung and Grinstein, 2007; Marone et al,
2008; Michell, 2008), we will highlight in the following the
many open questions that still dominate the ﬁeld. We will
also attempt to extract the general principles of the function-
ing of the PI system, and ﬁnally, we will illustrate how a
systems biology approach to the study of the genetic defects
of the PI-metabolising enzymes can provide important les-
sons for the understanding of the PI system itself.
The roles of the PIs in membrane trafﬁcking:
organisers of molecular machineries and
regulators of membrane lipid composition
The main role of the PIs in membrane trafﬁcking involves the
spatially and temporally controlled activation, recruitment
and/or assembly of the molecular machineries (see Table I)
involved in membrane bending and ﬁssion, and in vesicle
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2457movement, tethering and fusion. The components of these
machineries are mainly peripheral proteins that are targeted
to their correct sites of action through their binding to a
speciﬁc PI species. These PI–protein interactions usually
occur with relatively low afﬁnities, and additional stabilising
binding sites are often required to engage either membrane-
resident proteins or speciﬁc-organelle-associated small
GTPases (Lemmon, 2008). A similar combinatorial recogni-
tion system increases the individuality of the identity code
for each organelle and membrane domain, and offers an
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Behnia and Munro, 2005). Various examples of such integra-
tion are known: many adaptors (e.g. the clathrin adaptors
AP1 and AP2) share binding to the same coat protein
(clathrin) and the same sorting signals in the cargo proteins
(YXXF), but they are recruited to different intracellular
‘districts’ (trans-Golgi network (TGN) endosomes for AP1,
and plasma membrane (Bai and Chapman) for AP2), which is
here probably due to their different PI-binding selectivities
(Table I).
The PIs also operate at the interface between membranes
and the cytoskeleton, a key site for fundamental membrane
trafﬁcking events, such as membrane deformation and ﬁs-
sion, and vesicle movements. The importance of actin-based
machineries in endocytic processes is well established both in
yeast and in mammals (Engqvist-Goldstein and Drubin,
2003). In particular, actin assembly accompanies the inter-
nalisation of coated pits at the plasma-membrane (PM) in
yeast (Engqvist-Goldstein and Drubin, 2003), and a burst of
localised actin polymerisation accompanies the cycling of
synaptic vesicles. This cycling also correlates with the cycling
of PtdIns 4,5-bisphosphate (PI45P2) production/consump-
tion, and PI45P2 does indeed have an active role in coordi-
nating endocytic and cytoskeleton events (Di Paolo and De
Figure 1 The PI kinases and phosphatases and their genetic defects. (A) Schematic representation of the PI metabolic cycle with the PIKs
indicated in blue, and the PI phosphatases in green. (B) Listing of the different isoforms of the PIKs and PI phosphatases, together with their
domain organisation and their corresponding genetic disease and knockout or knockdown phenotypes in mice. RSBD, regulatory subunit-
binding domain; C2, conserved region 2; HD, helical domain; PRD, proline-rich domain, NLS, nuclear localisation signal; LKU, lipid kinase
unique domain; PH, pleckstrin-homology domain; SRD, serine-rich domain; CRD, cysteine-rich domain; FYVE, Fab1 YOTB Vac1 EEA1; DEP,
domain present in dishevelled, EGL-10 and pleckstrin; TCP1, tailless complex polypeptide-1; SPEC, spectrin repeat; PH-GRAM, pleckstrin
homology glucosyltransferases, Rab-like GTPase activators and myotubularins; DENN, differentially expressed in normal versus neoplastic; LZ,
leucine zipper; TM, transmembrane domain; ASH, abnormal spindle-like microcephaly-associated protein (ASPM), C. elegans centrosomal
protein (SPD-2), hydrocephalus-associated protein (Hydin); RhoGAP, Rho-GTPase-activating protein; SAC, yeast suppressor of actin 1; Skitch,
SKIP carboxyl homology domain; SH2, phosphotyrosine-binding module 2; SAM, sterile alpha-motif domain.
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Figure 2 Subcellular distribution of the PIs and PI-metabolising enzymes. The localisation of the different PIKs (blue) and PI phosphatases
(green), as well as the predominant PI species (as visualised by PI-binding protein domains) in the different cell compartments. It is noted that
many of the PI-metabolising enzymes are present in more than one cellular compartment, and their overall distributions do not completely ﬁt
with the PI map, as indicated using the PI-binding protein probes (see text for details). The PIKs and PI phosphatases are indicated according to
the nomenclature given in Figure 1. PM, plasma membrane; EE, early endosome; SE: sorting endosomes; RE, recycling endosome; LY,
lysosome; MVB/LE, multivesicular body/late endosome; PAS, pre-autophagosomal structure; PH, phagosome; TGN, trans-Golgi network; GC,
Golgi complex; ER: endoplasmic reticulum; N, nucleus.
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Cox et al (2002) Phagocytosis PH PI345P3 Myosin X
Hokanson et al (2006)
Glut4 trafficking and Golgi–PM  
trafficking PH PI45P2 Myosin 1C
Hoepfner et al (2005) Sorting at endosomes PX PI3P, PI345P3 KIF16B
Horiguchi et al (2006) Neuronal vesicles transport FHA PI345P3 GAKIN/KIF13B
Spudich et al (2007) Golgi–PM and endocytic vesicle
transport
ND PI45P2 Myosin VI
Aoyagi et al (2005) Regulated exocytosis ND PI45P2 SNAP25/Syntaxin1A
Klopfenstein et al (2002) TGN–PM and synaptic vesicles from 
transport PH PI45P2 KIF1A 
Watson et al (2005); 
Toyoshima et al (2007)
ER–Golgi and endosome–TGN 
transport ND PI345P3 Dynein/dynactin
Yu et al (2007) Regulated exocytosis C2 PI45P2 Exophilin4/Slp-2
Lee et al (2002) Endocytosis Exon10 PI45P2 Amphiphysin 2-Bin1
Burd and Ernr (1998) Endosomes FYVE PI3P EEA1
Nielsen et al (2000) Endosomes FYVE PI3P Rabenosyn5
Bai and Chapman (2003) Regulated exocytosis C2 PI45P2 Synaptotagmin
Liao et al (2007) Regulated exocytosis Hydrophobic region PI45P2 SCAMP2
Xu et al (2001) Endosomes TGN trafficking PX PI3P SNX3
Liu et al (2006) Sorting at endosomes PX PI4P, PI5P, PI35P2 SNX5
Shin et al (2008) Sorting at endosomes PX PI3P, PI34P2, PI35P2,
PI45P2
SNX9
Qin et al (2006) Endocytosis PX PI3P SNX10
Zheng et al (2001) Sorting at endosomes PX PI3P=PI5P>PI35P2, PI4P SNX13
Hanson and Hong (2003) Endo-lysosomal trafficking PX PI3P SNX16
Czubayko et al (2006) Sorting at endosomes PX PI3P SNX17
Teo et al (2006) Endo-lysosomal trafficking GLUE PI3P>PI34P2 ESCRTII
Lin et al (2005) Endo-lysosomal trafficking ND PI3P, PI35P2 ESCRTIII
Burger et al (2000) Severing vesicles and tubules from 
the TGN and PM
PH PI45P2 Dynamin1, 2, 3
Dai et al (2007) Phagocytosis ND PI3P VAMP8
Itoh et al (2001) Endocytosis ENTH PI45P2 Epsins 1–3
Wang et al (2007) Sorting at TGN GAT PIP4 GGAs
Mishra et al (2002) Endocytosis PTB PI45P2 Dab2
Mishra et al (2002)  Endocytosis ND PI45P2 ARH
Gaidarov et al (1999) Endocytosis ND PI45P2 β-Arrestins
Raiborg et al (2001) Sorting at endosomes FYVE PI3P Hrs
Cozier et al (2002) Sorting at endosomes PX PIP3, PI35P2, PI3P SNX1
Ford et al (2001) Endocytosis ANTH PI45P2 AP180/CALM
Kalthoff et al (2002) Formation of clathrin-coated vesicles  ENTH PI4P, PI35P2, PI45P3, PIP3 CLINT
Hyun et al (2004) Endocytosis ENTH PI45P2, PI34P2, PI35P2 HIP1/HIP1R
Zhong et al (2002) Sorting at endosomes PX PI3P>PI4P>PI5P SNX2
Hirst et al (2003) Sorting at endosomes ENTH PI4P EpsinR
Rohde et al (2002) Endocytosis Positively charged patch PI45P2 AP-2α, AP-2μ
Lee et al (1997) Endo-lysosomal trafficking ND PI45P2 AP3
Kam et al (2000) Sorting at endosomes PH PI45P2, PIP3 ASAP1
Nie et al (2002) Endo-lysosomal trafficking PH PI45P2 AGAP1
Nie et al (2005) Endo-lysosomal trafficking PH PI45P2 AGAP2
Vitale et al (2000) Endocytosis ND PI345P3 GIT1
Vitale et al (2000) Vesicle budding at the Golgi ND PI45P2 ArfGAP1
Liu et al (2001)
Coatomer assembly
ND PI45P2 ArfGAP3
Garcia-Gonzalo et al (2004) Endocytosis RLD1 PI45P2 HERC1
Chung et al (1998) Secretion C2 PI45P2 Rabphilin3A
Wang et al (2003) TGN–endosome trafficking Positively charged patch PI4P AP-1γ
Jackson et al (2000) Sorting at endosomes PH PI45P2 ACAP2
Shinozaki-Narikawa et al
(2006)
Sorting at endosomes PH PI45P2, PI34P2, PI35P2, PIP3 ACAP1
Tanaka et al (1997) Endocytosis PH (multiple) PI345P3 Centaurin 1α
Krugmann et al (2002) Endocytosis PH (multiple) PI345P3 ARAP3
Yoon et al (2006) Endocytosis PH (multiple) PI345P3 ARAP2
Miura et al (2002) Endocytosis PH (multiple) PI345P3 ARAP1
Macia et al (2008)  Endocytosis PH PI45P2 EFA6
Venkateswarlu et al (1999) Phagocytosis PH PI345P3 Cytohesin-1
Manna et al (2007) Endocytosis PH PI45P2, PI345P3, PI34P2 ARNO
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RLD1, RCC1-like domain; ENTH, epsin N-terminal homology; ANTH, AP180 N-terminal homology; GAT, GGA and Tom1; PTB, phospho-
tyrosine-binding domain; PX, Phox homology; FHA, forkhead associated.
PI-binding proteins belonging to membrane trafﬁcking machineries are shown according to their speciﬁc roles, together with their PI-binding
modules and their PI-binding preference.
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activity of PI45P2 during endocytosis belong to different
classes of proteins. These include the actin network growth
machinery proteins, including Cdc42, Arp2/3 and Abp1;
some of the so-called endocytic accessory proteins, such as
HIP1/HIP1R, which is recruited into growing coated struc-
tures and which connects the clathrin coat with actin ﬁla-
ments (Chen and Brodsky, 2005) and the actin-based myosin
I and VI motors (Krendel et al, 2007; Spudich et al, 2007),
which are believed to provide the required pulling force to
drive membrane deformation and ﬁssion (Table I). The PIs
are also involved in the subsequent cytoskeleton-driven en-
docytic steps, such as microtubule-dependent motility of
endosomes, where the PIs act on the motors (e.g. KIF16B;
Hoepfner et al, 2005) that mediate the plus-end-directed
motility of early endosomes, and that are required for recy-
cling and degradation pathways. Furthermore, the PIs appear
to coordinate the cytoskeleton and membrane trafﬁcking not
only at the PM and endosomes but also at the Golgi complex,
where they are involved in the assembly of a spectrin-based
actin skeleton (De Matteis and Morrow, 1998), in synergising
with Cdc42, NWASP and cortactin in Arp2/3-mediated actin
nucleation, and in the control of the Golgi pool of myosin VI
(Egea et al, 2006).
A further mechanism through which the PIs can affect the
properties of cell membranes and have an impact in membrane
trafﬁcking has emerged recently with the demonstration that
they can control the synthesis of the sphingolipids. This control
is mediated through a family of lipid-transfer proteins that
share a common domain organisation, and includes CERT
and FAPP2 (De Matteis et al, 2007). Thus, these possess a
closely homologous PH domain at their N terminus, and a
distinct additional lipid-binding/transfer domain at their C
terminus. Their homologous PH domains interact with
PtdIms4-phosphate (PI4P) and the small GTPase Arf, and are
responsible for the association of these lipid-transfer proteins
with the Golgi complex. Their distinct lipid-transfer domains
bind ceramide and glucosylceramide (GlcCer), for CERT and
FAPP2, respectively (D’Angelo et al, 2008).
CERT mediates the non-vesicular transport of ceramide
from the endoplasmic reticulum (ER), its site of synthesis, to
the Golgi complex, where it is converted into sphingomyelin
(SM). Consequently, defects in CERT inhibit SM synthesis
(Hanada et al, 2003). Lowering the levels of PI4P also inhibits
SM synthesis, through its impact on CERT recruitment/activ-
ity (Toth et al, 2006; D’Angelo et al, 2007).
FAPP2 is a GlcCer-transfer protein that is required for
complex glycosphingolipid (GSL) synthesis (D’Angelo et al,
2007; Halter et al, 2007) due to its ability to transfer GlcCer
from the cytosolic side of the early Golgi compartments to the
late-Golgi compartments, where the GSL synthetic enzymes
reside. This activity of FAPP2 is regulated by PI4P, and
interfering with PI4P production inhibits GSL synthesis
(D’Angelo et al, 2007).
The PIs as integrators of signalling and
membrane trafﬁcking
The PIs have recognised roles in membrane trafﬁcking also as
transducers of PM receptor activation and of the general
nutritional and stress status of the cell.
Well-known examples of the ability of the PIs to mediate the
effects of PM receptor-initiated signalling cascades on mem-
brane trafﬁcking include clathrin-mediated endocytosis (Irie
et al, 2005), phagocytosis (Stephens et al, 2002), macropino-
cytosis (Lanzetti et al, 2004), translocation of GLUT4 (Thong
et al, 2005) and degranulation of mast cells (Ito et al, 2002). A
more recent demonstration of how PM receptors regulate
trafﬁcking through the PIs relates to the involvement of the
PI 4-phosphatase Sac1 in the stimulation of anterograde traf-
ﬁcking in the Golgi complex in response to growth factors
(Blagoveshchenskaya et al, 2008). Sac1 accumulates at the
Golgi complex in quiescent cells, where it ‘consumes’ the
G o l g ip o o lo fP I 4 P ,a n db yd o i n gs o ,i td o w n r e g u l a t e sa n t e r o -
grade trafﬁcking. After stimulation by mitogens, Sac1 is phos-
phorylated and undergoes a transition from an oligomeric to a
monomeric state of aggregation. As a monomer, Sac1 is
relocated to the ER, resulting in an increase in PI4P levels at
the Golgi complex, and consequently in the promotion of
anterograde trafﬁcking (Blagoveshchenskaya et al,2 0 0 8 ) .
Local pools of the PIs can undergo signiﬁcant changes in
relation to nutrient availability and cell stress. In yeast,
nutrient availability appears to strictly control the pool of
PI4P at the Golgi complex, which is a key determinant in
anterograde trafﬁcking through and out of the Golgi complex
(Strahl and Thorner, 2007). Interestingly, nutrient deprivation
reduces the Golgi pool of PI4P (thus inducing a sort of
quiescent state of the organelle) by two parallel but synergis-
tic mechanisms: by releasing the PI 4-kinase (PI4K) Pik1p
(the major source for PI4P at the Golgi complex) from the
Golgi complex (Demmel et al, 2008); and by promoting the
translocation of the PI 4-phosphatase Sac1p from the ER to
the Golgi complex (Faulhammer et al, 2007).
With the PI response to cell stress, in their seminal paper
identifying PtdIms 3,5-bisphosphate (PI35P2) as a novel
endogenous PI species, Dove et al (1997) reported that
PI35P2 levels increase by up to 30-fold in yeast cells subjected
to hyperosmotic stress. This increase is mainly sustained by
an increased production of PI35P2 through the PIP5K Fab1p
(Cooke et al, 1998), with PI35P2 having a major role in
controlling the size and shape of the vacuole (Dove and
Johnson, 2007) and in mediating its fragmentation in re-
sponse to hyperosmotic stress (Bonangelino et al, 2002). A
remaining open question concerns the nature of the stress
sensors that lead to this increase in PI35P2 levels. An intri-
guing possibility is that the PIP5K Fab1p might itself function
as a stress sensor through its chaperonin-like domain (Dove
and Johnson, 2007).
The principles behind the organisation of PI
metabolism: compartmentalisation and
tight spatio-temporal control
A distinctive feature of the organisation of PI metabolism is
its regionalisation, as opposed to the centralisation of most
lipid biosynthetic pathways in the ER (and in the Golgi
complex). For the PIs, the ER is just the site of synthesis of
the common precursor, PtdIns, as all the subsequent steps of
phosphorylation (and dephosphorylation) occur in practi-
cally all the other cell compartments through the PIKs and
PI phosphatases (Figure 2). This regionalised organisation
and the isoform specialisation of PI metabolism have mani-
fold implications.
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phosphatases are different in each cellular compartment,
meaning that at steady state, each of the seven PI species
can maintain different concentrations across these compart-
ments. This non-homogeneous distribution of the PI species
in the cell has been ‘visualised’ using PI-binding protein
modules that have distinct PI-binding proﬁles (De Matteis
and Godi, 2004). With due caution deriving from an aware-
ness of the limits of these tools (Roy and Levine, 2004;
Lemmon, 2008), which can only detect the free pools of the
PIs and which can have protein as well as PI targeting
determinants (Godi et al, 2004; Lemmon, 2008), a distribu-
tion map of the PIs in the cell has been constructed. In this
map, PI45P2 is enriched at the PM, PI4Pat the Golgi complex,
PI3P at the early endosomes, and PI3P and PI35P2 in the late
endosomes. However, many ‘deviations’ from this main
distribution map have been described as a more assorted
series of tools have become available (Roy and Levine, 2004;
Lemmon, 2008) and more accurate methods of detection
are applied (Downes et al, 2003). Thus, it has been possible
to obtain direct visualisation and functional data in favour
of the presence of PI45P2 in the Golgi complex (Watt et al,
2002), of PI4P at the PM (Roy and Levine, 2004) and
at the micropexophagy-speciﬁc membrane apparatus
(Yamashita et al, 2007), of PI3P at the PM (Falasca et al,
2007; Lodhi et al, 2008) and of PI35P2 in secretory granules
(Osborne et al, 2008).
A question raised by this apparent spatial segregation of
the PI species into different and distant compartments is how
the global PI homoeostasis is maintained across the cell.
Different possibilities can be envisaged here. One is that the
PI homoeostasis is maintained due to intense communication
of the different PI pools through vesicular trafﬁcking. This
would establish a sort of bidirectional proﬁtable relationship,
where the PIs are used as organisers of membrane trafﬁcking,
and membrane trafﬁcking serves PI metabolism by ensuring
the delivery of PI substrates generated in a given compart-
ment to their metabolic enzymes located in a distant, but
communicating, one. Another possibility is that in spite of
hosting an apparently predominant PI species, each compart-
ment is in fact self sufﬁcient in sustaining an autonomous
phosphorylation–dephosphorylation PI cycle and thus con-
tains different PI species at the same time at steady state.
These two possibilities are not mutually exclusive and are
indeed both pursued with the differently located PI enzyme
isoforms that are involved in the generation of the same PI
product in a given cell compartment depending on the cell or
environmental conditions. This has been shown recently for
the origin of PI4P as a precursor for PI45P2 at the PM: this is
different under steady-state and stimulated conditions,
whereby for the former it arises from the Golgi-complex-
localised PI4Ks, PI4KIIa and IIIb, whereas in angiotensin-II-
stimulated cells it arises mainly from PI4KIIIa (Balla et al,
2008). Interestingly, although it cannot be excluded that a
small fraction of PI4KIIIa relocalises to the PM upon receptor
stimulation, the majority of this PI4K isoform resides in the
ER. This prompts the speculation that at least under these
circumstances, the generation of PI4P at the PM might occur
at the sites of close apposition between the ER and the PM
(the ER–PM contact sites; Levine and Loewen, 2006). This is
an additional and intriguing possibility for PI metabolic
reactions that has been shown to occur for other lipid
metabolic pathways, such as phosphatidylserine–phosphati-
dylethanolamine conversion at the level of the ER–mitochon-
dria membrane contact sites (Shiao et al, 1998).
The ability of the PIs to serve the multiple and dynamic
functions in membrane trafﬁcking mentioned above is due to
the tight spatial and temporal control of their generation/
consumption, that is, of the PIKs and PI phosphatases. These
are usually cytosolic enzymes that are timely and precisely
recruited to sites that are actively involved in trafﬁcking
events, through their interactions with key components of
the molecular machineries that control or carry out speciﬁc
transport steps. These include the small GTPases, coat/adap-
tors and the ﬁssioning machinery in particular (Table II).
Interestingly, these same classes of molecules are also often
targets of the PIs (Table II). Thus, the interactions of the
PI-metabolising enzymes with components of the trafﬁcking
Table II Interaction between PI-metabolising enzymes and components of membrane trafﬁcking machineries
Stein et al (2003) PIK3C3 Rab7
Hausser et al (2005)
Hinchliffe et al (2006)
Nishikawa et al (1998)
Shin et al (2008)
Craige et al (2008)
Krauss et al (2006)
Gaidarov et al (2001); Wheeler and
Domin (2006)
Santarius et al (2006)
Lichter-Konecki et al (2006)
Santarius et al (2006)
Godi et al (1999)
Lichter-Konecki et al (2006)
Christoforidis et al (1999)
Shin et al (2005)
Hyvola et al (2006)
PI4KB
PIP4K2A
PIK3C3
PIP5K1 
PI4K2
PKD
PIP5K1C AP2
PI4K2A AP3
PIP5K1A, B, C SNX9
PIP5K1
PI4KB
OCRL
ARF1
PIP5K1A, B, C
OCRL
ARF6
PI3KC2A, B Clathrin
PI3KC2A, B, G
PIK3C3
INPP4A
INPP5B
OCRL1
Rab5
Small 
GTPases
Accessory
proteins
Coats and
adaptors
Fission
PI enzymes Trafficking machinery
components References
Sorting
Components of molecular machineries involved in different steps of membrane trafﬁcking that control the localisation and/or activity of the PI-
metabolising enzymes.
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enzymes to speciﬁc cellular compartments but also to effec-
tively channel speciﬁc PIs to their effectors and to sustain
positive or negative feedback if the recruited enzymes pro-
duce or consume, respectively, the PI species that interacts
with the effector. The best studied examples of GTPases that
control the PI-metabolising enzymes are those of Rab5 and
the Arfs. Rab5 seems to be a key controller and coordinator of
the PIKs and PI phosphatases in the endocytic pathway, as it
binds and stimulates type III PI3K, type I PI3Kb, type I PI 4-
phosphatase and the INPP5B and OCRL 5-phosphatases (Shin
et al, 2005), whereas both Arf1 and Arf6 can recruit and
stimulate PIP5K (Santarius et al, 2006), with Arf1 also
recruiting and activating PI4KIIIb on the Golgi complex
(Godi et al, 1999).
The open questions on substrate
channelling, functional redundancy and the
general coordination of the PI-metabolising
enzymes
A peculiar feature of the PI system is the coexistence of
pathways that are both divergent (where the same PI species
is subjected to different and alternative modiﬁcations) and
convergent (where the same PI species is produced through
different routes). These features pose two important ques-
tions for which only partial answers are at present available:
(i) what are the mechanisms through which a given PI
species is channelled towards one of its different possible
products? and (ii) to what extent are the alternative pathways
leading to the same end product redundant or ‘dedicated’ to
different functions?
The answer to the issue of substrate channelling towards a
given product will need to come from a consideration of the
regionalised distribution of the different PI-metabolising en-
zymes that determines that the same PI species can have
distinct destinies in different locations (Figure 2). This could
thus explain, for instance, why PtdIns is mainly converted to
PI4P in the Golgi complex and into PI3P in the endosomes,
whereby PI4K and PI3K are differentially enriched in these
two compartments.
However, in many instances, different enzymes acting on
the same substrate coexist in the same compartment
(Figure 2), and together with the highly diffusible nature of
the PIs as substrates; this means that the spatial segregation
argument cannot be applied here.
A solution that appears to be pursued in some cases is the
preassembly of multi-enzyme complexes, which are generally
centred on regulatory/scaffold components. One of these
complexes controls the turnover of PI3P at the endosomes,
and includes a PI3K (Vps34), a PIP 3-phosphatase (MTM1)
and a regulatory component (Vps15) (Cao et al, 2007).
Another complex controls PI35P2 synthesis and turnover in
MVBs and contains the PIP5K PIKfyve, the PIP 5-phosphatase
Sac3 (a Fig4 homologue), and the regulatory component
ArPIKfyve (homologue of Vac14) (Sbrissa et al, 2007).
Other examples of multi-enzyme complexes in this context
include a complex isolated from platelets that contains PIP
5-phosphatases and 4-phosphatases and PI 3-kinases
(Munday et al, 1999), and a complex orchestrated by Rab5
that includes type I PI3K, PIP 4-phosphatase and PIP
5-phosphatase (Shin et al, 2005).
Interestingly, this latter complex has been shown to sustain
one of the two convergent pathways that leads to the produc-
tion of PI3P in the endosomal membranes: one which pro-
ceeds through the two-step dephosphorylation of PI345P3 in
positions 5 and 4, as opposed to the one which is based on
the direct phosphorylation of PIs by type III PI3K (Munday
et al, 1999; Shin et al, 2005). The production of PI45P2 can
also proceed through two convergent pathways: either by
5-phosphorylation of PI4P (by PIP5K1; Figure 1) or by
4-phosphorylation of PI5P (by PIP4KII; Figure 1).
A question that arises from the existence of convergent
pathways and of different enzyme isoforms (Figure 1) is to
what extent these pathways or enzyme isoforms are func-
tionally redundant or generate ‘specialised’ and distinct pools
of the PIs. This is a question that has not been systematically
and quantitatively addressed, and for which the solution will
be of extraordinary importance to exploit this, even if limited,
functional redundancy as a target in the treatment of diseases
linked to genetic defects of single PI-metabolising enzymes
(see below).
An aspect that has remained little explored to date relates
to the coordination of the PI enzymatic activities at both the
local and the global cellular levels. Locally, the small GTPases
have key roles, as they function as recruiters and timers for
the PI-metabolising enzymes (Table II), and in selected cases
(such as for Rab5), they can also coordinate multiple enzy-
matic activities. Another level of local homoeostatic control
appears to be intrinsic to the structures of the enzymes
themselves (Figure 1), as in addition to their catalytic do-
main, some of these possess additional PI-binding domains
with good afﬁnities for their substrate. This is the case, for
instance, of the 3-phosphatase MTMR4, which has a FYVE
domain that binds PI3P and that contributes both to its
recruitment and to its release once the substrate has been
removed by the enzyme itself (Lorenzo et al, 2006), or of
MTMR2, which is recruited, through its PH-GRAM domain,
to PI35P2-containing vesicles (Berger et al, 2003). A special
case is seen with PI35P2 synthesis in the vacuole in yeast:
here, Fig4 not only has 5-phosphatase activity towards
PI35P2 but also appears to activate the PIP5K Fab1 kinase
that synthesises PI35P2 from PI3P (Duex et al, 2006). Thus,
Fig4 regulates both the turnover and the synthesis of PI35P2.
A similar dual regulation might be very effective in ensuring
that PI35P2 undergoes continual production that is balanced
by continual consumption, and thus promoting an elevated
ﬂux of PI35P2 through a phosphorylation–dephosphorylation
cycle. An elevated PI35P2 ﬂux is an elegant way to increase
the local availability (without raising the absolute levels) of
PI35P2 and to reduce its diffusion.
Another way to exploit the coordination of the activities of
the PIKs and PI phosphatases is to subject them to common
regulation through phosphorylation–dephosphorylation cy-
cles through shared protein kinases and phosphatases. This
is the case for PI45P2 synthesis and turnover at the synapse,
which are both inhibited through Cdk5-mediated phosphor-
ylation and inactivation of PIP5KC and synaptojanin, and are
activated by calcineurin-mediated dephosphorylation of both
PIP5K and synaptojanin (Lee et al, 2004).
At present, we have scattered examples of the mecha-
nisms that coordinate the local activities of the different
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to the existence of a more general plan for the coordination
and speciﬁc combination of the expression and/or inter-
actions in the cell of given PI-metabolising enzyme isoforms
that function along the same or alternative PI-metabolising
branches. Deciphering such a plan will be important for the
unravelling of the ‘real’ physiological roles of apparently
equivalent pathways that can operate through the coupling
of different enzyme isoforms. Similarly, this will enable us to
determine the tissue speciﬁcities of the different pathways,
and to identify the pathopathways underlying the diseases
that derive from genetic defects in single PI-metabolising
enzymes and the drug targets for the treatment for these
diseases (see below).
Help towards the answering these questions may well arise
from the application of a systems biology approach to the
study of the PI-metabolising enzymes. By combining and
completing the data for the expression proﬁles and protein
interactions of these enzymes (and of the PI targets), this
approach should arrive at the deﬁnition of the ‘interactome’
of the PI system. An example of an analysis of co-expression
proﬁles of PI-metabolising enzymes is given in Figure 3. By
centring the analysis on 3-phosphatases and 5-phosphatases
and selecting the genes for PI-metabolising enzymes that are
among the most signiﬁcantly co-expressed genes, a number
of PI-enzyme clusters emerge. It turns out, for instance, that
the OCRL gene, which is responsible for Lowe syndrome (see
below), is part of a highly interconnected gene cluster that
comprises PIP5K1A, INPP5A, PI3KC2A and MTMR1. Thus, the
expression of two 5-phosphatases, OCRL and INPP5A (a type
I 5-phosphatase acting exclusively on soluble inositol phos-
phates and involved in inositol 1,4,5-trisphosphate removal),
seems to be coordinated with that of a PI45P2-synthesising
enzyme, speciﬁcally PIP5K1A. This co-expression proﬁle
might represent the basis for homoeostatic control of
PI45P2 and inositol 1,4,5-trisphosphate levels, and might
provide an explanation for the calcium-signalling imbalance
that occurs when PI45P2 levels increase due to a mutation
in OCRL (Suchy et al, 2005). Furthermore, the signiﬁcant
co-expression of OCRL with MTMR1 suggests a possible role
for OCRL in the control of the endocytic PI3P pool.
Although limited, the example given shows the power
of such an approach for the uncovering of unsuspected
couplings between speciﬁc isoforms of the PI-metabolising
enzymes, for the provision of candidate interactors and
for the delineation of novel pathways of communication
SYNJ2
PIK3R2
PIK3CD
INPP5F
MTMR4
MTMR9
PIP5K3
MTMR6
MTMR12
SACM1L
INPP4B
SYNJ1
INPP5A
PIP5K1A
MTMR1
PIK3C2A
SBF2
PIK3R1
Kinase
Phosphatase
PIK3C3
MTMR14
MTMR8
MTMR10
PI4KA OCRL
PTEN
INPP5D
Figure 3 Co-expression network of the PI-metabolising enzymes. Co-expression network of the PI-metabolising enzymes (PIKs, blue ellipses;
PI phosphatases, green ellipses; as listed in Figure 1), focused on the 3- and 5-phosphatases. The analysis was performed using the COXPRESdb
database of gene expression proﬁles from a variety of normal and pathological conditions (from a total of 123 experiments; Obayashi et al, 2008
no. 22). Here, using the 3- and 5-phosphatase genes as individual queries and analysing the most signiﬁcantly co-expressed genes (according to
the weighted Pearson’s correlation coefﬁcient between gene probes, and choosing 0.4 as a threshold; Obayashi et al, 2008), we selected
speciﬁcally for the genes for PI-metabolising enzymes. Groups of genes extensively connected in the network represent co-expressed gene
clusters that are likely to be involved in common cell functions. The 3- and 5-phosphatase genes responsible for genetic diseases (see Figure 1)
are highlighted in bold. Four interconnected enzyme clusters emerge from the analysis, each containing a disease gene (see Figure 1). In
particular, OCRL gene is part of a cluster that also comprises PIP5K1A, INPP5A and MTMR1.
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their relevance can and will have to be explored experimen-
tally.
What we can learn from the genetic
diseases of the PI system?
The importance of maintaining a tight balance between the
activities of the various PI-metabolising enzymes is high-
lighted by the severe consequences arising from defects in PI
metabolism. The pivotal roles of PI345P3 dysmetabolism in
cancer, inﬂammation and diabetes are well established
(Cantley, 2004; Wymann and Marone, 2005), to the point
where the PI3Ks and the PI345P3 phosphatases PTEN and
SHIP have become attractive targets for the development of
novel pharmacological agents (Workman, 2004; Lazar and
Saltiel, 2006; Ruckle et al, 2006; Zhao, 2007).
For monogenic diseases that have been linked to defects in
PI-metabolising enzymes, these represent a heterogeneous
group of conditions, many of which affect the nervous system
(both central and peripheral; such as lethal contractural
syndrome, Lowe syndrome and Marie–Charcot–Tooth), with
others affecting muscle (myopathy), eye (ﬂeck corneal dys-
trophy, Lowe syndrome) and kidney (Lowe syndrome)
(Figure 1). In the majority of cases, we do not understand
in depth the links connecting the genetic defects with the
clinical manifestations of these diseases. A lot of help in this
direction should come from consideration of pathological
states with similar clinical pictures, as it has now been
shown that diseases with overlapping clinical manifestations
can be caused by mutations in different genes that are part of
the same functional module. In such instances, the clinical
overlap can be attributed to defects in individual genes that
render the entire module dysfunctional. Analyses involving
model organisms, and more recently humans, have also
shown that direct and indirect interactions often occur be-
tween protein pairs that are responsible for similar pheno-
types (Oti, 2007). Recently, this concept has been successfully
applied and exploited to identify and experimentally conﬁrm
the relationships between genes involved in various inherited
ataxias that all share a dysfunctional state of the Purkinje
cells (Lim et al, 2006).
Figure 4 shows the results of a similar approach (based on
the available data) as it might be applied to one of the main
manifestations of Lowe syndrome: a dysfunction of the
kidney proximal tubule cells (PTCs) that is responsible for
the loss of salts (including bicarbonates) and low molecular
weight (LMW) proteins with the urine (Igarashi et al, 2002;
Christensen and Gburek, 2004). This proximal tubular acido-
sis and LMW proteinuria are pathognomic of the renal
Fanconi syndrome, which is common to a series of genetic
defects that involve intracellular chloride channels (ClC5 in
Dent syndrome) and ion transporters or exchangers (SLC9A3,
SLC34A1 and SLC4A4). In some cases, the extent of the
overlap of clinical signs is such that the conditions cannot
be distinguished: this is the case for patients who have been
clinically diagnosed as affected by Dent disease, but have
then been found to carry mutations in OCRL (Attree et al,
1992; Hoopes et al, 2005). Building up a comprehensive
network including the mouse genes where a knockout causes
protein and/or salt urinary loss (Figure 4, rectangles), and the
interactors of the human gene products that show the defects
causing renal Fanconi syndrome (Figure 4, large ellipses)
highlight the molecular pathways that are involved in protein
and salt reabsorption by PTCs and provide a range of testable
candidates as possible OCRL interactors and/or PI45P2-bind-
ing proteins (yellow ellipses) with proven physiological roles
in PTCs (Figure 4). A key node in the network illustrated in
Figure 4 is megalin (LRP2), a member of the LDL receptor
family that is highly expressed in the brush border of PTCs,
and that functions together with cubilin (CBN) as a multi-
ligand receptor that mediates the capture and resorption of
the LMW proteins present in the ultraﬁltrate (indicated as
megalin ligands in Figure 4) (Igarashi et al, 2002; Christensen
and Gburek, 2004). Megalin and cubilin continuously cycle
between the apical PM, and the early/recycling endosomes,
with delivery of luminal ligands to the lysosomal compart-
ments, escorted by PI-binding proteins, such as Dab2
(Disabled-2) and ARH (autosomal recessive hypercholester-
olaemia). A defect in megalin recycling has been shown to be
at the origin of Dent disease (Piwon et al, 2000), and has been
hypothesised to contribute to urinary protein loss also in
Lowe syndrome (Norden et al, 2002; Lowe, 2005). This
hypothesis has been experimentally reinforced recently by
the demonstration that OCRL interacts with APPL1, which in
turn binds GIPC, an interactor of megalin (Erdmann et al,
2007).
Finally, introducing a similar phenome analysis in our PI
studies will not only allow us to delineate candidate patho-
pathways for pharmacological intervention in the genetic
defects of the PI-metabolising enzymes, but when integrated
with the interaction network of these PI-metabolising en-
zymes, it will also greatly improve our overall understanding
of the global organisation of PI metabolism and of the real
physio-pathological relevance of its numerous branches.
Conclusions and perspectives
Through work carried out over the last decade on yeast and
mammalian cell models in many laboratories, we have now
reached a deep state of knowledge of the molecular details of
the regulation and roles of several of the PI-metabolising
enzymes. However, we are still missing the overall picture of
the global functional organisation and coordination of the PI
system. An answer to this problem should arise from the
computational integration of phenotypic data (derived from
genetic diseases and knockout mice) with a high-conﬁdence
interaction network of the PI-metabolising enzymes and their
regulators and effectors; thus from a combined PI-phenome-
interactome network.
Despite these many residual uncertainties, we are, how-
ever, also convinced that it is time to translate the many
research discoveries of these past years towards the develop-
ment of pharmacological treatments for genetic diseases that
involve the PI-metabolising enzymes. The main considera-
tions here are three-fold: ﬁrst, powerful drug discovery
technologies are now available; second, the diseases that
are related to the PI-metabolising enzymes fulﬁl the general
criteria for drug discovery as they originate from defects
within molecular pathways where it is possible to identify
‘drugable’ targets and third, some of these PI-metabolising
enzymes (e.g. PI3K, SHIP and PTEN) are indeed already drug
targets and have inspired the development of highly speciﬁc
inhibitors. The legitimate conclusion that we reach is that the
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Figure 4 Interaction map of the products of the genes responsible or candidate for disorders of kidney proximal tubule cells (PTCs). The genes
responsible or strong candidate for diseases due to dysfunction of kidney PTCs are shown (large red ellipses), together with selected interactors,
including genes for which the knock out causes proteinuria and tubular acidosis in mice (rectangles). The interaction map was generated using
Osprey (powered by Human GRID, General Repository of Interaction Datasets). The components of the network that are active on or sensitive to
PI45P2 (the substrate of the 5-phosphatase OCRL) are marked in yellow. LRP2 encodes for megalin, a multiligand receptor that, together with cubilin
(CBN), is responsible for the resorption of the indicated LMW proteins by PTCs (Igarashi et al, 2002; Christensen and Gburek, 2004). ARH,
autosomal recessive hypercholesterolaemia; DAB2, disabled homologue 2; GIPC, GAIP C terminus interacting protein; PIP5K1C, phosphatidylino-
sitol-4-phosphate 5-kinase type I gamma; SYNJ2BP, synaptojanin 2-binding protein; CLTC, clathrinh e a v yc h a i n1 ;A P 2 M 1 ,c l a t h r i nc o a ta s s e m b l y
protein AP50, Myo VI, myosin 6, APPL1, adapter protein containing PH domain, PTB domain and leucine zipper motif 1; Arf6, ADP ribosylation
factor 6; PIP5KL1, phosphatidylinositol-4-phosphate 5-kinase-like 1; SYNJ2, synaptojanin-2; RAC1, Ras-related C3 botulinum toxin substrate 1;
RhoA, transforming protein RhoA; IP3R, inositol 1,4,5-trisphosphate receptor type 1; AHCYL1, putative adenosylhomocysteinase 2; SLC9A1, Na/H
exchanger 1 (NHE-1) (solute carrier family 9 member 1); ARHGDIA, Rho GDP dissociation inhibitor 1 (Rho GDI 1); ARHGDIB, Rho GDP dissociation
inhibitor 2 (Rho GDI 2); PIK3R1, phosphatidylinositol 3-kinase regulatory alpha subunit; EZR, Ezrin; SLC4A8, solute carrier family 4, sodium
bicarbonate cotransporter, member 8; SLC9A3R1, Na(þ)/H(þ) exchange regulatory cofactor NHE-RF) (NHERF-1); SLC9A3R2, Na(þ)/H(þ)
exchange regulatory cofactor NHE-RF2 (NHERF-2); PLCB1, phospholipase C-beta-1; ACTA1, alpha actin 1; ACTC, alpha cardiac actin.
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involving the PI cycle is ripe. Therefore, greater efforts now
need to be put into the exploitation of our basic knowledge
for the identiﬁcation and validation of drug targets.
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